Haya Therapeutics, a Swiss biotech pioneering RNA

A recent study published in the

Australian-led research project lands $11.

A recent study published in the journal

A recent study has uncovered that

Longevity.

Recent research published in

A recent report published in

Study shows semaglutide has ‘far-reaching bene

Platform integrates health data from hundreds of

Longevity.

Osmotin, a powerful plant protein, is gaining re

A comprehensive study published in

Cellular rejuvenation company aims to advance ne

Bats play a vital role in maintaining the ecosys

Urolithin A is gaining recognition for its power

Longevity.

Aging drug discovery conference demonstrates tha

Imagine remembering where you left your keys or

Recent research has unveiled groundbreaking insi

Have you ever felt jittery after a couple of cup

Longevity.

You may have noticed small changes in your memor

Highly anticipated conference returns to Switzer

Companies file joint patents relating to synergi

Recent research has unveiled profound disparitie

Walking has surged in popularity across the Unit

Collaboration between LT, Founders Forum and NUS

Targeting inflammatory diseases, company gears u

Longevity.

DdrC protein repairs broken DNA fragments, resto

Are you struggling to keep up with the relentles

Wouldn’t it be beneficial to understand how to

Longevity.

Mary Lou Jepsen’s latest $100m venture leverag

L-theanine, a naturally occurring amino acid fou

Longevity.

More than 160 speakers to present as the world’s largest aging drug discovery conference opens its doors. In the glorious settings of The University of Copenhagen, the largest conference on aging in the biopharmaceutical industry kicks off its proceedings today, beginning a full week of sessions, speakers and workshops. The 11th annual Aging Research and Drug Discovery conference (ARDD) once again brings together the world’s leading authorities on the science of aging and how to target the aging process in humans to enable healthier and longer lives for all. In addition to ARDD’s always stellar academic lineup, the 2024 conference boasts an incredibly strong presence from leading biotech companies in the aging field, further boosted by the presence of pharma companies including Lilly, Lundbeck, Novartis, Regeneron and others. Another significant focus of this year’s event is on longevity medicine, with an entire track dedicated to the translation from basic science towards the clinic and the implications for practicing physicians. ARDD’s home is in Denmark at the University of Copenhagen. Alongside Insilico Medicine boss Alex Zhavoronkov, ARDD is chaired by University of Copenhagen professors Morten Scheibye-Knudsen and Daniela Bakula. “I’m extremely happy about the program – we have an incredible lineup…

According to a study published in

In a striking display of disparity within the Un

Victoria Forest on how a new longevity city in G